Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system.

Background Chronic spontaneous urticaria (CSU) is a common problem worldwide. We evaluated the direct medical costs of treating patients with refractory CSU and the budget effect of omalizumab use in these patients in Kuwait.